SCHEMBL2017387

SCHEMBL2017387

Cc1cc(C(=O)N(C)C(CCNC(=O)c2cccn2C)Cc2ccccc2)ccn1

nearest known ligand 0.71

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
HCRTR1 O43613 2/20 0.71
HCRTR2 O43614 2/20 0.71
NPC1 O15118 2/20 0.47
RAB9A P51151 2/20 0.47
PADI4 Q9UM07 3/20 0.39
HRH3 Q9Y5N1 2/20 0.39
HDAC6 Q9UBN7 2/20 0.37
HDAC3 O15379 1/20 0.37
HDAC4 P56524 1/20 0.37
HDAC1 Q13547 1/20 0.37
HDAC7 Q8WUI4 1/20 0.37
HDAC2 Q92769 1/20 0.37
HDAC10 Q969S8 1/20 0.37
HDAC8 Q9BY41 1/20 0.37
HDAC5 Q9UQL6 1/20 0.37
KDM4E B2RXH2 1/20 0.34
KDM5A P29375 1/20 0.34
KDM5C P41229 1/20 0.34
KDM5B Q9UGL1 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2011910 0.90 HCRTR1 (0.69) HCRTR1HCRTR2NPC1RAB9APADI4
SCHEMBL2015025 0.89 HCRTR1 (0.70) HCRTR1HCRTR2NPC1RAB9APADI4
SCHEMBL2017217 0.88 HCRTR1 (0.64) HCRTR1HCRTR2NPC1RAB9APADI4
SCHEMBL2015950 0.87 HCRTR1 (0.70) HCRTR1HCRTR2NPC1RAB9APADI4
SCHEMBL2013242 0.87 HCRTR1 (0.70) HCRTR1HCRTR2NPC1RAB9APADI4
SCHEMBL13139060 0.87 HCRTR1 (0.77) HCRTR1HCRTR2NPC1RAB9APADI4
SCHEMBL13139093 0.86 HCRTR1 (0.77) HCRTR1HCRTR2NPC1RAB9AHRH3
SCHEMBL13139102 0.86 HCRTR1 (0.71) HCRTR1HCRTR2NPC1RAB9APADI4
SCHEMBL2013804 0.86 HCRTR1 (0.73) HCRTR1HCRTR2NPC1RAB9APADI4
SCHEMBL2014068 0.85 HCRTR1 (0.65) HCRTR1HCRTR2NPC1RAB9APADI4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2011073316-A1 4-ARYL-BUTANE-1,3-DIAMIDES NOVARTIS AG (CH) 2011-06-23 WO claimed
WO-2011073316-A1 4-ARYL-BUTANE-1,3-DIAMIDES NOVARTIS AG (CH) 2011-06-23 WO disclosed